Atlas Trials

A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

Clinical trial NCT06283303 · UNKNOWN

Trial details

NCT number
NCT06283303
Sponsor
China Medical University, China
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Colorectal Cancer Metastatic
Start date
2024-04-02
Primary completion
2025-11-30
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.